Overview

A Dose-finding Study of Silodosin in Patients With Urinary Calculi

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and the safety of silodosin in urinary calculi patients.
Phase:
Phase 2
Details
Lead Sponsor:
Kissei Pharmaceutical Co., Ltd.
Treatments:
Silodosin